28-07-2021 19:00 via medpagetoday.com

Aducanumab Glass Half Empty. No, It's Half Full

(MedPage Today) -- Three opinion pieces published Wednesday in the New England Journal of Medicine may end up in business school classes as a case study in how one set of facts, about which no one disagrees, can generate starkly different interpretations...
Read more »